Volume 15; Issue supp-S2

Main
European Neuropsychopharmacology
Volume 15; Issue supp-S2

European Neuropsychopharmacology

Volume 15; Issue supp-S2

1

P.1.043 Searching for 5-HT2- and 5-HT3-receptorantagonists as a potential neuropsychotropic agents

D.S. Yakovlev, I.I. Goryagin, M.V. Chernikov, A.A. Spasov, V.A. Anisimova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 201 KB

english, 2005

2

L.1 Mechanism of individual responses to emotional stress and tranquilizers

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 86 KB

english, 2005

3

L.2 Current status of genetics of bipolar disorder

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 86 KB

english, 2005

4

S.1.1 Animal modeling of depressive disorders

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 303 KB

english, 2005

5

S.1.2 Cellular plasticity in response to antidepressant treatment

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 205 KB

english, 2005

6

S.1.3 Depressive episodes: Nosology andtherapy

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

7

S.1.4 Comorbidity of depression and anxiety

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 94 KB

english, 2005

8

S.2.1 Translation of animal models to humanpsychopathology

L. Groenink, B. Olivier

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 202 KB

english, 2005

9

S.2.2 Experimental models of anxiety

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 109 KB

english, 2005

10

S.2.3 Stress related disorders: Approach todiagnosis and treatment

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 213 KB

english, 2005

11

S.2.4 Underlying pathology and treatment of social phobia

J. Zohar, C. Sheba

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

12

S.2.5 Is there still a place for benzodiazepines?

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 202 KB

english, 2005

13

S.2.6 Treatment of anxiety disorders

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 99 KB

english, 2005

14

S.3.1 Polymorphism of dopamine system genesand predisposition to alcoholism and drug addiction

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 108 KB

english, 2005

15

S.3.2 Endorphins and addiction

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 207 KB

english, 2005

16

S.3.3 Behavioral mechanisms of nicotine abuse: Search for novel pharmacotherapies to treat nicotine dependence

A.Y. Bespalov, E.S. Zakharova, I.M. Sukhanov, E.E. Zvartau

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 101 KB

english, 2005

17

S.3.4 New approaches to treatment of pathologicalcraving for psychoactive substances

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

18

S.3.5 Treatment of addiction

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

19

S.4.1. Vasopressin and neurotensine moleculesand the aging brain

R.U. Ostrovskaya, T.A. Gudasheva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 103 KB

english, 2005

20

S.4.2 Neurodegenerative diseases and oxidative stress

J. Emerit, M. Edeas

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 203 KB

english, 2005

21

S.4.3 Aging and brain degeneration

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 102 KB

english, 2005

22

S.4.4 Complex relationships exist betweenAlzheimer's disease (AD) and depression

P.H. Robert, E. Michel, S. Clairet, M. Benoit

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 177 KB

english, 2005

23

S.4.5 New approaches to Alzheimer's diseasetherapy: Role of neurotrophic stimulation

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 78 KB

english, 2005

24

P.1.001 Lithium oxybutirate and circadianrhythms of renal sodium, potassium, lithium and calcium excretion in rats with right suprachiasmatic nucleus lesion

T. Zamoshchina, M. Meleshko

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 92 KB

english, 2005

25

P.1.002 Melatonin and circadian rhythms of Na+,K+, Ca2+ contents in blood, brain and urine of rats during summer solstices

T. Zamoshchina, K. Shraim, E. Ivanova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 189 KB

english, 2005

26

P.1.003 Influence of the lithium salts on circadianrhythm of the Li+ excretion with urine in conditions of round-the-clock darkness

T.A. Zamoshchina, L.N. Novitskaja, E.V. Ivanova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 204 KB

english, 2005

27

P.1.004 Anxiety affects the developmentof experimental pain—depressive syndromes in two rat models

N.A. Krupina, I.N. Orlova, N.N. Khlebnikova, V.S. Smirnova, V.N. Grafova, M.L. Kukushkin, V.I. Rodina

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

28

P.1.005 Comparative study of pharmacological activity of antidepressants fluoxetine and tianeptine

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 211 KB

english, 2005

29

P.1.006 Combination of bemithyl and pyrazidolas an antiasthenic tool in delayed posttraumatic period

I.P. Zarubina, F.N. Nurmanbetova, P.D. Shabanov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 108 KB

english, 2005

30

P.1.007 Positive influence of new chemical agent fluoglizine on behaviour of male mice with anxiety/depression-like state

I.L. Kovalenko, D.F. Avgustinovich, I.V. Sorokina, T.G. Tolstikova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 204 KB

english, 2005

31

P.1.008 Potentiation of analgesic andantidepressive effects after intramuscular and oral administration of adrenaline, cholecystokinin and polyvinylpyrrolidone combinations

S.E. Serdyuk, V.E. Gmiro

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 99 KB

english, 2005

32

P.1.009 L-tryptophan modulates behavioralprocesses at disbalance of thyroid hormones

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 203 KB

english, 2005

33

P.1.010 Neuropharmacological effects of threehypericum species in an open field test

A. Capasso, G. Diana, E. Quaranta, V. De Feo

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 107 KB

english, 2005

34

P.1.011 Central action of 9-[2-(4isopropylphenoxy)ethyl] adenine on brain neurotransmission

O.Yu. Ananyeva, N.V. Onishchenko

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 215 KB

english, 2005

35

P.1.012 Sex and brain regional differences intissue levels of excitatory amino acids in a rat model of depression

E. Anderzhanova, N. Kokras, C. Dalla, K. Antoniou, Z. Papadopoulou-Daifoti

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 208 KB

english, 2005

36

P.1.013 5-HT1A receptors modulate behavior and c-fos expression in ovariectomized rats in forced swim test

J.O. Fedotova, N.S. Sapronov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 99 KB

english, 2005

37

P.1.014 Regional oxidative metabolismas measured by cytochrome c oxidase histochemistry in rats with low or high exploratory activity: Implications for depression

J. Harro, D. Matrov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 207 KB

english, 2005

38

P.1.015 Imipramine-induced rapid ejaculation inrats

I.V. Belozertseva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 212 KB

english, 2005

39

P.1.016 Chronopharmacological resemblance of antidepressant and anxiolytic drugs

E.V. Bayer, E.B. Arushanian

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

40

P.1.017 The role of clinical, psychologicaland demographic factors in effect of thymoanaleptic treatment of depression disorders

L.S. Kanaeva, D.F. Ibragirnov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

41

P.1.018 Serum dehydroepiandrosterone sulfate and cortisol levels in patients with different types of depression

Y.A. Kochetkov, K.V. Beltikova, L.N. Gorobets

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 102 KB

english, 2005

42

P.1.019 Typology of seasonal depressions

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 205 KB

english, 2005

43

P.1.020 Degree of improvement in depressivepatients who have committed suicide attempts

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

44

P.1.021 Predictors of antidepressant tolerabilityin patients with depressive disorders

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 200 KB

english, 2005

45

P.1.022 Resistant depression treatment:rTMS vs ECT

E. Tsukarzi, S. Ilyin, S. Mosolov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 97 KB

english, 2005

46

P.1.023 Clinical and psychological predictorsof pharmacotherapy refusals in patients with non-psychotic depressions

V.I. Borodin, I.I. Puchkov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 200 KB

english, 2005

47

P.1.024 Paroxetine versus amitriptylinein the long-term treatment of recurrent depression (open randomized active control study)

A.N. Gorodnichev, E.G. Kostukova, S.N. Mosolov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 105 KB

english, 2005

48

P.1.025 Electroencephalographic evaluation ofplacebo and antidepressants action in patients with depression

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 209 KB

english, 2005

49

P.1.026 Spectral analysis of EEG changes indepressed patients exposed to TMS

S. Kapiletti, T. Melnikova, E. Tsukarzi, S.N. Mosolov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 107 KB

english, 2005

50

P.1.027 Paroxetine in heroin addiction treatment

M.L. Rokhlina, T.A. Kitkina, G.A. Gubanov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 208 KB

english, 2005

51

P.1.028 Comparison of anxiety anddepression levels in patients with central nervous system disorders and patients with neuromuscular pathology

V.N. Grigorieva, E.N. Gusanova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

52

P.1.029 The influence of sertraline andmianserine on some bivalent cations in patients with major depression

M. Nechifor, C. Văideanu, I. Mândreci, I. Palamaru, P. Boişteanu

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 203 KB

english, 2005

53

P.1.030 Double-blind, placebo-controlled,multicenter study evaluating nemifitide, a new pentapeptide antidepressant, when given daily or every other day for three weeks in the treatment of major depressive disorder

J.P. Feighner, L. Sverdlov, J. Hlavka, G. Nicolau, G. Tonelli, J. Freed

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 101 KB

english, 2005

54

P.1.031 Use of sibutramine, an inhibitor of thereuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: A placebo-controlled study

A. Casella, W. Milano, C. Petrella, A. Capasso

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 204 KB

english, 2005

55

P.1.032 Treatment of bulimia nervosa with fluvoxamine: A randomized controlled trail

C. Siano, W. Milano, C. Petrella, A. Capasso

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 105 KB

english, 2005

56

P.1.033 If antiepileptics are mood stabilisers isepilepsy an affective disorder?

G. Djokic, D. Lazic, I. Dimitrijevic, N. Zivkovic, S. Milivojevic, S. Jakulic-Mrkic

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 201 KB

english, 2005

57

P.1.034 Menopausal hysterical depression asa form of pathological development of personality disorder

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 99 KB

english, 2005

58

P.1.035 Comparative pharmacoeconomic analysis of effectiveness of the combined therapy provided to the children with depressive behavioral disorder arising on the background of residual-organic brain lesion

Y.V. Redkin, T.I. Ivanova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

59

P.1.036 The treatment of organic affective disorders in liquidators of the accident at Chernobyl Atomic Station using the indices of quality of life (QoL) and social functioning

Y.V. Redkin, M.M. Aksenov, T.V. Dvorkina

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 213 KB

english, 2005

60

P.1.037 Psychiatric, psychological and neurological characteristics of patients with chronic low back pain

K.O. Chakhava, E.M. Ershova, E.V. Podchufarova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 110 KB

english, 2005

61

P.1.038 The use of lidevine in complex treatment of heroin patients abusing alcoholic beverages

T.N. Doudko, V.V. Chirko

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 215 KB

english, 2005

62

P.1.039 Prospective course of illness andanxiety disorder comorbidity in 83 bipolar I and 44 bipolar II patients followed in a tertiary center

M.S. Mian, V. Menniti, F. Nardini, A. Litta, L. Macchia, F. Lenzi, A. Benedetti, L. Lattanzi, L. Musetti, F. Soldani, G.B. Cassano

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 109 KB

english, 2005

63

P.1.040 New approach to development of low-dose CNS-active drug

T.G. Tolstikova, A.O. Bryzgalov, I.V. Sorokina, S.E. Tolstikov, I.L. Kovalenko, D.F. Avgustinovich

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 105 KB

english, 2005

64

P.1.041 Chronobiological effect of propranolol in the treatment of depression

S. Andruskevicius

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 203 KB

english, 2005

65

P.1.042 Epidemiological analysis of theprevalence rate of the depressive syndrome among children in Omsk city T.I. Ivanova O.E. Krakhmaleva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 100 KB

english, 2005

66

P.1.044 Clinical efficacy of vasopressin in thetreatment of poststroke depression

S.G. Tsikunov, S.G. Belokoscova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 103 KB

english, 2005

67

P.1.045 Psychotropic drugs and homeostatic systems: Mechanism of psychoneuroimmunomodulation

V.Ya. Semke, S.A. Ivanova, T.P. Vefugina, N.A. Bokhan

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 206 KB

english, 2005

68

P.1.046 Transcranial magnetic stimulation in combination with antidepressant drugs in major depression: Preliminary results

D. Rossini, A. Lucca, R. Zanardi, E. Smeraldi

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 201 KB

english, 2005

69

P.2.001 Effects of olanzapine and verapamilcombination on the neurotransmitter content in Wistar rat brain structures

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 97 KB

english, 2005

70

P.2.002 Conformationally constrained analogues of antipsychotic dipeptide N-caproyl-L-prolyl-L-tyrosine methyl ester

A.N. Ignashin, N.I. Zaitseva, M.V Retunskaya

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 97 KB

english, 2005

71

P.2.003 Amisulpride in the treatment of patients with somatoform disorders

C. Văideanu, M. Nechifor, P. Boişteanu

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 97 KB

english, 2005

72

P.2.004 Open comparative randomized studyefficacy and tolerability of risperidone, olanzapine and quetiaine in acute mania

D.V Belenkaya, M.V Kuzavkova, S.N. Mosolov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 97 KB

english, 2005

73

P.2.005 Circulatory levels ofcatecholamines and serotonin in neuroleptic malignant syndrome

D. Malin, B. Spivak, Y. Vered, V. Kozyrev, R. Ravilov, S. Mosolov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 100 KB

english, 2005

74

P.2.006 Combined olanzapine-ECT therapy forresistant schizophrenia

E. Oleneva, E. Tsukarzi, S. Mosolov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 100 KB

english, 2005

75

P.2.007 Analysis of the action of antipsychotics in a 5-factor model of schizophrenia

M.V. Kuzavkova, A.V. Eremin, S.N. Mosolov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 198 KB

english, 2005

76

P.2.008 Comparative clinical efficacy of atypicalantipsychotics and haloperidol in treatment of acute schizophrenia relapses

A.N Eremin, M.V. Kuzavkova, S.N. Mosolov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 101 KB

english, 2005

77

P.2.009 The efficacy of laser therapy in pharmacoresistant schizophrenia

M.A. Saikin, E.E. Tsukarzi, S.N. Mosolov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 200 KB

english, 2005

78

P.2.010 The shift of alpha rhythm of EEG in patients with schizophrenia during long-term treatment by atypical antipsychotics

G. Soulimov, T. Melnikova, V. Kalinin, S.N. Mosolov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 102 KB

english, 2005

79

P.2.011 Obstetric complication and bipolar disorders: A systematic review and meta-analysis of bipolar disorders compared with healthy controls, unipolar disorders and schizophrenia

J. Scott, Y. McNem, J. Cowanagh, M. Cannon, R. Muway

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 200 KB

english, 2005

80

P.2.012 The −1727 A/T, −50 C/T and (CAA)n repeat GSK-3β gene polymorphisms and resistance to antipsychotics in schizophrenia

S. Bignotti, C. Scassellati, C. Bonvicini, L. Bocchio-Chiavetto, B. Rossi, J. Perez, R. Randazzo, M. Gennarelli

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 100 KB

english, 2005

81

P.2.013 Safety and efficacy of long-acting risperidone in schizophrenia: A 12-week, open-label study in stable patients switched from typical and atypical oral antipsychotics

M. Cetin, S. Ebrinc, C. Basoglu, U.B. Semiz, H. Gunay, M.S. Iyisoy, B.M. Ergun, C. Gunes, A. Sahan, M. Oguz, O. Noyan

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 206 KB

english, 2005

82

P.2.014 The effect of DHEA administrationon extrapyramidal symptoms in schizophrenia: A randomized double blind placebo controlled trial

T. Nachshoni, T. Ebert, Y. Abramovitch, M.M. Asael-Amir, A. Weizman, M. Kotler, R.D. Strous

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 212 KB

english, 2005

83

P.2.015 Correlation between antipyrine metabolism and neuroleptic load in shizophrenic patients

L.E. Ziganshina, O.O. Vedernikova, A.V Kuchaeva, F.F. Gatin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

84

P.2.016 Influence of atypical neuroleptic on cell apoptosis in patients with schizophrenia in the course of the therapy

S.A. Ivanova, A.V. Semke, N.M. Rakitina, O.A. Lobacheva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 205 KB

english, 2005

85

P.2.017 Use of actovegin in complex care ofresidual-organic psychosyndrome in children

E. Malinina, O. Pilyavskaya, I. Zabozlayeva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 103 KB

english, 2005

86

P.2.018 Sudden deaths among hospitalized psychiatric patients

P. Benatov, S. Abramov, P. Sirota

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 199 KB

english, 2005

87

P.2.019 Serotonin 2A receptor gene T102C polymorphismand the response to treatment with second-generation antipsychotics in schizophrenia

A. Juhász, A. Rimanóczy, G. Szekeres, S. Kéri, Z. Janka

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 98 KB

english, 2005

88

P.2.020 Treatment with risperidone in earlyonset of psychotic decompensations in adolescents

M. Graovac, D. Petrić, A. Kaltelan, T. Frančišković, Lj. Moro

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 192 KB

english, 2005

89

P.2.021 Effects of atypical neurolepticquetiapine on blood indices, humoral immunity and body weight in patients with schizophrenia

O.A. Lobachoyva, T.P. Vetlugina, A.V. Semke, S.V. Evseyev, L.P. Pytina, S.O. Kabanov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 96 KB

english, 2005

90

P.2.022 Efficacy of a psychoeducationalprogram for weight gain control in patients taking olanzapine

S. Castrogiovanni, M. Simoncini, N. Iovieno, D. Cecconi, G. Dell'Agnello, P. Donda, S. Grazzini, A. Rossi, M. Mauri

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

91

P.3.001 Discriminative stimulus effects of mexidol in rats

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 202 KB

english, 2005

92

P.3.002 Discriminative stimulus effects of cycloprolyl-glycine

E.V. Petlyanina

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 99 KB

english, 2005

93

P.3.003 The effect of Selank on the seasonal depressed animal behaviour

T.P. Semenova, I.I. Kozlovsky, A.V. Zuikov, E.N. Karavaev

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 198 KB

english, 2005

94

P.3.004 Repeated aggressive experience and efficacy of anxiolytics

N.P. Bondar, N.N. Kudryavtseva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 101 KB

english, 2005

95

P.3.005 The influence of 5-HT1A receptor agonists ipsapirone and buspirone on anxious-depressive mice: Comparison of acute and chronic treatments

D.F. Avgustinovich, O.V. Alekseyenko, L.A. Koryakina

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

96

P.3.006 Can diazepam improve reduced socialand sexual behavioral reactions in anxious male mice?

A.V. Amikishieva, S.N. Semendyaeva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 200 KB

english, 2005

97

P.3.007 Influence of the ACHT(4–10) analogue Semax on anxiety and analgesia induced by different stressors

D.A. Vilensky, D.M. Ivanova, N.G. Levitskaya, L.A. Andreeva, A.A. Kamensky, N.F. Myasoedov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 98 KB

english, 2005

98

P.3.008 Ex vivo investigation of afobazole effect on H3-diazepam binding by synaptoneurosomal membranes of inbred mice and rats

M. Yarkova, M. Voronin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 200 KB

english, 2005

99

P.3.009 Anxiolytic properties of afobazole incomparison with diazepam

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 105 KB

english, 2005

100

P.3.010 The psychopharmacological analysis ofLadasten effects

M. Voronin, M. Yarkova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 205 KB

english, 2005

101

P.3.011 Genetic dependence of CCK-2 antagonistsand agonists psychotropic effects

L.G. Kolik, T.A. Gudasheva, S.B. Seredenin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 103 KB

english, 2005

102

P.3.012 Influence of Ladasten on monoamineslevel in Maudsley reactive and Maudsley non-reactive rats

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 97 KB

english, 2005

103

P.3.013 Anxiolytic properties of 5-HT3-receptorantagonists

M.V. Chernikov, A.A. Spasov, V.A. Anisimova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 193 KB

english, 2005

104

P.3.014 Pharmacological validation of a newmodel of anxiety in rats and mice — the Suok (“ropewalking”) test: Sensitivity to diazepam and pentylenetetrazole

A.V. Kalueff, P. Tuohimaa

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 99 KB

english, 2005

105

P.3.015 Influence of neurotensin microinjections into dorsal raphe nucleus on passive avoidance performance in rats

N.P. Shugalev, A.V. Stavrovskaya, G. Hartmann, L. Lénárd

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 198 KB

english, 2005

106

P.3.016 The activity of amygdala galaninergicsystem in regulation of stress-induced anxiety behavior

V.I. Lioudyno, S.G. Tsikunov, A.G. Pshenichnaya, V.M. Khmenko

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 101 KB

english, 2005

107

P.3.017 Effect of afobazole on brain-derived neurotrophic factor protein in brain of inbred mice exposed to emotional stress

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 206 KB

english, 2005

108

P.3.018 Neuropharmacological effects of heptapeptide Selank on the neurotransmitter content in brain structures of Wistar rats

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 107 KB

english, 2005

109

P.3.019 Interstrain differences in neurotransmitters response in BALB/c and C57BI/6 mice after open field stress

A.S. Lapitskaia, V.S. Kudrin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 204 KB

english, 2005

110

P.3.020 Emotional stress induced dominantlethal mutations in mice which may be prevented by a tranquilizer

N.O. Daugel-Dauge, A.D. Durnev

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 100 KB

english, 2005

111

P.3.021 Biologically active conformation of cholecystokinin-4 retropeptide analogues with anxiolytic activity

E.P. Kir'yanova, L.G. Kolik, T.A. Gudasheva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 99 KB

english, 2005

112

P.3.022 Antistressory effect of mexidol in inbredC57BL/6 and BALB/C mice

A.K. Sariev, O.Yu. Kravtsova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 99 KB

english, 2005

113

P.3.023 Induction of chromosome aberrationsafter emotional stress and its correction by phenazepam in mice

A.V. Kulakova, A.D. Durnev

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 201 KB

english, 2005

114

P.3.024 Anxiolytic afobazole defends the genome from adverse action of chemical mutagens

A.K. Zhanataev, E.A. Bosych

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 105 KB

english, 2005

115

P.3.025 Electrophysiological characteristics ofsingle neuron responses to anxiolytic drugs in different brain structures

I.N. Sharonova, V.S. Vorobjev, S.N. Kolbaev, M.B. Kozhemyakin, V.G. Skrebitsky

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 208 KB

english, 2005

116

P.3.026 Pharmacokinetics of peptide anxiolytic Selank in rat blood and brain after intranasal administration

Yu.A. Zolotarev, O.Yu. Sokolov, V.S. Kozik, N.V. Kost, E.M. Dorokhova, V.K. Meshavkin, A.K. Dadayan, M.V. Gabaeva, A.A. Zozulya, N.F. Myasoedov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 105 KB

english, 2005

117

P.3.027 Kinetic analysis of the processelimination after single and different schemes of multiple administration of cinazepam — A novel prodrug possessing psychotropic activity

O.V. Zhuk, V.G. Zinkovsky, S.I. Schukin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 96 KB

english, 2005

118

P.3.028 Neuropharmacological properties of 1-(phenylpiperazinylbutyl) acids

S.A. Andronati, T.L. Karaseva, S.U. Makan, G.E. Kolodeev, A.V. Golturenko, A.Y. Bogatsky

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 185 KB

english, 2005

119

P.3.029 Neuropharmacological properties of 1-aryl-4[(naphtalimido)alkyl]pipe razines

A.V. Golturenko, T.L. Karaseva, A.F. Galatin, S.G. Soboleva, S.A. Andronati, A.Y. Bogatsky

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 92 KB

english, 2005

120

P.3.030 Anxiety and depressive disorders in late postoperative period of coronary artery bypass graft surgery (CABG)

M.A. Samuchia, D.A. Beskova, K.O. Vecherinina

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 197 KB

english, 2005

121

P.3.031 Influence of chronical neonatal injectionof arginine-vasopressin and its C-terminal analogue on the postponed behaviour in white rats

O.G. Voskresenskava, A.A. Kamensky, V.P. Golubovich

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 109 KB

english, 2005

122

P.3.032 Dependence of Semax long-lasting effects on the time of its neonatal administration

E.A. Sebentsova, N.G. Levitskaya, L.A. Andreeva, A.A. Kamensky, N.A. Myasoedov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 208 KB

english, 2005

123

P.3.033 The role of gestational acute stress inthe development of perinatal pathologies

A.V. Graf, M.V. Maslova, A.S. Maklakova, N.A. Sokolova, Ja.V. Krushinskaya, E.N. Goncharenko, A.A. Bayzhymanov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 101 KB

english, 2005

124

P.3.034 Pharmacological activity of new1,4-benzodiazepine derivatives — Esters of 3-hydroxyphenazepam and high aliphatic acids

I.A. Kravchenko, A.I. Sivko, N.V. Ovcharenko, V.B. Larionov, V.I. Pavlovskiy, S.A. Andronati

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 190 KB

english, 2005

125

P.3.035 The profile of anti-anxiety action of tofisopam in the treatment of generalized anxiety disorder

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 91 KB

english, 2005

126

P.3.036 Novel anxiolytic Selank: Results of thePhase II clinical trials

G.G. Neznamov, E.S. Teleshova, V.K. Bochkarev, V.V. Koschelev, T.S. Syunyakov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 197 KB

english, 2005

127

P.3.037 Results of clinical study of ladasten, a drug with stimulatory and anxiolytic activity

S.A. Syunyakov, S.A. Grishin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 109 KB

english, 2005

128

P.3.038 Peculiarities of action of anxiolyticafobazole in patients from different typological groups

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 213 KB

english, 2005

129

P.3.039 Phase-I investigation of selective anxiolytic afobazole

N.V. Kolotilinskaya, B.A. Badyshtov, A.L. Makhnycheva, S.A. Nadorov, M.A. Yarkova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 107 KB

english, 2005

130

P.3.040 A comparison of clinical efficacy andsafety of proproten and diazepam for the treatment of anxiety disorders

J.L. Dugina, A.V. Martyushev-Poklad, O.I. Epstein, S.A. Sergeeva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 210 KB

english, 2005

131

P.3.041 Clinical and neurophysiologicalefficacy of neurofeedback in the combined therapy of anxiety disorders resistant to psychopharmacotherapy

E.N. Biriukova, I.N. Timofeev, S.N. Mosolov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 207 KB

english, 2005

132

P.3.042 Possible pharmaceuticaladaptation of premedication to out-patient dental treatment

S.A. Rabinovich, S.G. Novikova, E.G. Lobanova, D.V. Novikov, T.V. Emehanova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 103 KB

english, 2005

133

P.3.043 Use of proproten for premedication ofpatients in the dental practice

L.I. Larentsova, S.A. Sergeeva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 198 KB

english, 2005

134

P.3.044 Posttraumatic and psychogenicdisturbances in veterans of modern war

M.A. Sherman, A.I. Novoselov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 98 KB

english, 2005

135

P.3.045 Unlicensed and off-label sedatives prescription in the cardiology and cardiosurgery pediatric care units

M. Panovic-Bajcetic, N. Divac, R. Samardzic, S. Simeunovic, M. Prostran

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 99 KB

english, 2005

136

P.3.046 The natural course of obsessive compulsive disorder over four years: Findings from a prospective community study of adolescents and young adults

R. Lieb, L. Schwender, A. Nocon, H. Pfister, K.-U. Wittchen

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 99 KB

english, 2005

137

P.3.047 The benefits of usingtherapeutic approaches to improve social adaptation of patients with neurotic and somatoform disorders

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

138

P.3.048 The application of pharmacological drugs for the correction of psychoemotional state in extreme conditions

A.A. Ikhalaynen

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 210 KB

english, 2005

139

P.3.049 New selective anxiolytic afobazole:Profile and efficiency for treatment of different structures of anxiety disorders

S.A. Syunyakov, D.V. Chumakov, L.E. Mametova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 108 KB

english, 2005

140

P.3.050 The efficiency of the methods of psychoemotional state correction in modelling conditions

A.A. Tishchenko

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 208 KB

english, 2005

141

P.3.051 Estimation of placebo effect in therapyof generalized anxiety disorder

V.O. Chakhava, O.V. Chemikh

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 103 KB

english, 2005

142

P.3.052 Obsessive doubts (“Folie du doute”)

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 196 KB

english, 2005

143

P.3.053 Multivariate statistical analysis of healthy volunteers' individual sensitivity to benzodiazepine tranquilizers

S.A. Nadorov, A.L. Mahnycheva, B.A. Badyshtov, N.V. Kolotilinskaya, M.N. Levina

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 97 KB

english, 2005

144

P.3.054 Possibility of predicting the effects of benzodiazepine tranquilizers

B.A. Badyshtov, N.V. Kolotilinskaya, A.L. Mahnycheva, S.A. Nadorov, M.N. Levina

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 99 KB

english, 2005

145

P.3.055 Alprazolam: Clinical dynamics in neurotic disorders

I.E. Kupriyanova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 99 KB

english, 2005

146

P.3.056 Peripheral-type benzodiazepine receptorbinding sites in platelets of patients with panic disorder associated to separation anxiety symptoms

S. Pini, C. Martini, M. Abelli, M. Montali, B. Chelli, M. Muti, M. Preve, A. Lucacchini, G.B. Cassano

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

147

P.3.057 Mirtazapine and venlafaxine administration in alcohol detoxification: Impact on anxiety and depression symptoms

E. Tzavellas, J. Liappas, T. Paparrigopoulos, C. Kontoangelos, P. Theodoropoulos, C.R. Soldatos

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 205 KB

english, 2005

148

P.4.001 Use of DNA/Protein Array for profiling transcription factors activated by aminoadamantane compound Ladasten in rat brain

I.V. Vakhitova, M.Kh. Salimgareeva, R.S. Yamidanov, S.B. Seredenin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 101 KB

english, 2005

149

P.4.002 Prolactin levels during the treatmentwith atypical antipsychotic agents

L.N. Gorobets, L.G. Ermolaeva, J.A. Kochetkov, A.V. Litvinov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 203 KB

english, 2005

150

P.4.003 Psychosomatic types at cerebral-asthenic residual-organic genesis at children

L. Benko, N. Butorina, G. Butorin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

151

P.4.004 The sense of coherence, quality of life and symptoms of anxiety and depression in patients with cataract

M. Hyper-Ochalik, K. Piekarska, K. Poftorak, I. Krupka-Matuszczyk

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 205 KB

english, 2005

152

P.4.005 Relationships between biopharmaceuticaland pharmacokinetic data in the series of 1,4-benzodiazepines

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

153

P.4.006 Optimization of new anxiolytic drug formulations on the basis of pharmacokinetic researches

V.P. Zherdev, G.B. Kolyvanov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 209 KB

english, 2005

154

P.4.007 The delayed effects of neonatalbuspirone injections on aggressivity in adult males in two mouse lines

N.V. Markina, O.V. Perepelkina, I.B. Fedotova, I.I. Poletaeva, G.I. Kovalev

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

155

P.4.008 Cholinergic modulation of sexual behaviorafter stress: Behavioral correlations

A.A. Bairamov, I.N. Zaichenko, O.M. Efremov, N.A. Borovskih, N.A. Losev, N.S. Sapronov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 213 KB

english, 2005

156

P.4.009 Cholinergic modulation ofsexual behavior after stress: Neurochemical correlations

A.A. Bairamov, I.N. Zaichenko, O.M. Efremov, K.J. Senchik, N.A. Losev, N.S. Sapronov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 206 KB

english, 2005

157

P.4.010 Antidepressant therapy effects infibromyalgia patients

M. Atarowska, M. Sobieska, E. Gajewska, W. Samborski

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 99 KB

english, 2005

158

P.4.011 Effects of Tyr-MIF-1 family of peptides on antinociception after immobilization stress in rats

A.I. Bocheva, E.B. Dzambazova-Maximova, A.D. Logofetov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

159

P.4.012 Embryonic serotonin deficiency changes activity of 5-HT3 receptors implicated in prolonged pain mediation in the formalin test in adult rats

L.P. Butkevich, V.A. Mikhailenko, M.N. Leont'eva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 207 KB

english, 2005

160

P.4.013 Application of new supplementwith antioxidant properties at aging (experimental data)

A.A. Spasov, V.A. Kosolapov, A.V. Stepanov, V.B. Pisarev, G.L. Snigur, A.E. Bulanov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 105 KB

english, 2005

161

P.4.014 Comparative study of Ladasten, Sydnocarb and their combination effects

M.N. Levina, B.A. Badyshtov, I.V. Rybina, M.M. Kozlovskaya

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 203 KB

english, 2005

162

P.4.015 Comparative study of the impact of combinedSydnocarb-Ladasten on physical work ability of laboratory animals

M.N. Levina, B.A. Badyshtov, I.V. Rybina, M.M. Kozlovskaya

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 100 KB

english, 2005

163

P.4.016 Place of psychopharmacotherapy in complex treatment of patients with bronchial asthma and chronic obstructive pulmonary disease

V.N. Krasnov, N.V. Martynova, T.S. Melnikova, N.K. Chereyskaya

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 202 KB

english, 2005

164

P.4.017 Protection against organophosphates inducedirreversible acetylcholinesterase inhibition by concomitant administration of donepezil and pyridostygmine

M. Kowalczyk, M. Brytan, O. Antkowiak

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

165

P.4.018 Male aromatase-knockout mice exhibit normal levels of activity, anxiety and “depressive-like” symptomatology

C. Dalla, K. Antoniou, Z. Papadopoulou-Daifoti, J. Balthazar, J. Bakker

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

166

P.4.019 Comparative description of transcutaneous conductivity of Silicic Glycerohydrohelium

T.G. Bovakovskava, L.P. Larionov, T.G. Honina

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 209 KB

english, 2005

167

P.4.020 Effect of MgCl2·6H2O with vitamin B6 on the emotional status and magnesium content in brain structures of rats fed with magnesium-deficient diet

A.A. Spasov, I.N. Iezhitsa, N.V. Onischenko, N.V. Churbakova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 210 KB

english, 2005

168

P.4.021 Theoretical conformational analysis of antidepressants as a way for evaluation of their efficiency for pain and itch syndrome management in patients with end-stage renal disease under chronic hemodialysis

N.N. Shestakova, N.P. Vanchakova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

169

P.4.022 Changes in gene expression profiles in rat brain induced by Ladasten

R.S. Yamidanov, J.V. Vakhitova, S.B. Seredenin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 208 KB

english, 2005

170

P.4.023 Role of main pathways signal transductioninvolved in realization of pharmacological effects of Ladasten in rat brain

M.Kh. Salinigareeva, I.V. Vakhitova, S.B. Seredenin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

171

P.4.024 Serotonin transporter gene polymorphism as a possible modifying factor of individual response to stress

M.V. Alfimova, G.I. Korovaitseva, L.I. Abramova, V.G. Kaleda, V.E. Golimbet

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 213 KB

english, 2005

172

P.4.025 Effects of stress and positive reinforcement on processes of defensive behavior habituation

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 207 KB

english, 2005

173

P.4.026 Melatonin in the treatment of children with sleep disorders

H.F. Ayyash, R. Morton, H. Alfanek, Ph. Preece

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 100 KB

english, 2005

174

P.4.027 The hypertensive ISIAH rat strain offers promise in pharmacological research of arterial hypertension and aggressive behavior

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 100 KB

english, 2005

175

P.4.028 Toxic influence of the new adenine derivative VMA-98-17 on neurologic status of rats

I.A. Myagkova, D.G. Kovalev, A.A. Ozerov, M.S. Novikov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 101 KB

english, 2005

176

P.4.029 The effect of new N-acetyl-L-asparticacid analogue on dopamine release and synthesis in the rat brain

V.S. Sergeyev, N.V. Onishchenko

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 101 KB

english, 2005

177

P.4.030 Sex differences in the effects ofultra-low doses of naltrexone on morphine analgesia in rats

E.V. Shekunova, I.N. Belozertseva, A.Yu. Bespalov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 207 KB

english, 2005

178

P.4.031 General characteristics of acute phase proteins in fibromyalgia patients

M. Sobieska, M. Atarowska, E. Gajewska, W. Samborski

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 109 KB

english, 2005

179

P.4.032 The development of polyunsaturated fatty acids with dopamine and serotonin in their structures for platelet activity regulation

T.M. Vasilieva, V.A. Makarov, G.N. Petrukhina, V.V. Bezuglov, N.M. Gretskaya

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 105 KB

english, 2005

180

P.4.033 New nonpeptide ASIC's ligands in experiments “in vitro”

L.B. Piotrovsky, E.V. Litasova, M.A. Dumpis, S.V. Kulikov, G.N. Tokar, O.O. Krishtal

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 208 KB

english, 2005

181

P.4.034 Autoimmune responses to proteins HLDF and S100b as pathogenic factors and molecular markers of cerebrovascular diseases

E.I. Elistratova, N.E. Yakovleval, V.V. Sherstnev, I.S. Denischuk, V.V. Yurasov, I.A. Kostanyan, E.A. Shirokov, V.I. Skvortzova, M.A. Gruden

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 105 KB

english, 2005

182

P.4.035 Influence of food-derived opioid peptides on behaviour and learning ability of white rat pups

I.S. Stovolosov, J.A. Belyaeva, V.A. Dybynin, A.A. Kamensky, J.D. Bespalova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 209 KB

english, 2005

183

P.4.036 Influence of pinealectomy on the course of pharmacological effect after acute and chronic administration of psychotropic drugs

A.V. Popov, E.B. Arushanian, A.P. Popova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

184

P.4.037 Study of mechanisms of the ACTH(4–10) analogue SEMAX analgesic activity

D.M. Ivanova, D.A. Vilensky, N.G. Levitskaya, L.A. Andreeva, A.A. Kamensky

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 205 KB

english, 2005

185

P.4.038 The influence of hypotonic swellingand hyportonic shrinking on intracellular sodium concentration in rat brain synaptosomes

T.V. Waseem, L.P. Lopatina, S.V. Fedorovich, S.V. Konev

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 101 KB

english, 2005

186

P.4.039 Effects of gabapentin on tactile allodynia induced by chronic constriction injury in rats

A.A. Malyshkin, E.V. Shekunova, I.N. Belozertseva, A.Yu. Bespalov, W. Danysz

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 205 KB

english, 2005

187

P.4.040 The influence of food-derived opioid peptide β-casomorphin-7 on mother-dependent albino rat pups behaviour

V.A. Dubynin, J.A. Ivleva, J.A. Belyaeva, I.S. Stovolosov, J.V. Dobryakova, L.A. Andreeva, A.A. Kamensky

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

188

P.4.041 The effect of ultra small doses of thyroliberin on structural changes of biological membranes in vitro

V.E. Zhernovkov, N.P. Pal'mina

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 207 KB

english, 2005

189

P.4.042 Experimental and clinical evaluation ofneurotropic effect of ecdysten

V.N. Syrov, Z.A. Khushbaktova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 203 KB

english, 2005

190

P.4.043 Autonomic and behavioral effects ofintracerebroventricular injected CRF

V.N. Gourine, D.P. Dvoretsky, S.A. Polenov, D.M. Poputnikov, E.V. Melenchuk, O.A. Azev, A.G. Chumak, A.V. Gourine

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 101 KB

english, 2005

191

P.4.044 Influence of various psychotropic drugson human retinal functions

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

192

P.4.045 Chronopharmacology of drugsimproving cognitive brain functions

E.B. Arushanian

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

193

P.4.046 Long-term experience of psychotropic drugs application for treatment of comorbid mental disorders in general hospital inpatients

V.N. Prokudin, A.P. Mouzychenko, I.V. Evstigneeva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 210 KB

english, 2005

194

P.4.047 The influence of the immunotropicpharmacotherapy on life-quality rates and the expression of astheno-vegetal syndrome at the herpetic infection

Yu.V. Redkin, A.Yu. Odokienko

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 204 KB

english, 2005

195

P.4.048 Early complex developmental diagnosisand early intervention programme for children born with very low birth weight

E. Gajewska, M. Sobieska, W. Samborski

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 97 KB

english, 2005

196

P.4.049 Preliminary findings from ADORE Italy: Untreated attention-deficit/hyperactivity disorder is a significant burden on the patient and family

G. Dell Agnello, P. Curatolo, F. Mancini, R. Pino, A. Rossi, M.J. Lorenzo, S.J. Ralston

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 199 KB

english, 2005

197

P.5.001 Experimental study ofstress-conditioned changes in animal behavior caused by sleep deprivation after administration of GABA imidazole derivative

L.E. Borodkina, M.N. Bagmetov, V.V. Epishina, A.V. Voronkov, I.N. Tyurenkov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

198

P.5.002 Comparative study of psychotropicactivity of pyridine derivatives of γ-aminobutyric and glutamic acids

A.V. Voronkov, M.N. Bagmetov, V.V. Epishina, L.E. Borodkina, I.N. Tyurenkov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 206 KB

english, 2005

199

P.5.003 Nootropic and anxiolytic effects onrepeated functional disruptions of avoidance responses in rats

A.N. Inozemtsev, T.L. Garibova, I.G. Kapitsa, T.A. Voronina

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 206 KB

english, 2005

200

P.5.004 Search for neuroprotective substancesamong the derivatives of GABA for treating ischemic stroke

I.N. Tyurenkov, L.E. Borodkina, M.N. Bagmetov, V.V. Epishina, A.V. Voronkov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 102 KB

english, 2005

201

P.5.005 Novel antiparkinsonian drug hemantane

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 203 KB

english, 2005

202

P.5.006 Electrophysiological analysis of the hemantane effects in rats with MPP+-induced parkinsonism

I.G. Kapitsa, L.N. Nerobkova, L.M. Sharkova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 103 KB

english, 2005

203

P.5.007 Perspectives of the use of a new antioxidant mexidol in the treatment of Parkinson's disease

L.N. Nerobkova, E.A. Katunina, T.A. Voronina, E.A. Malykhina, I.G. Kapitsa, R.K. Arakelyan, G.N. Avakyan

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 198 KB

english, 2005

204

P.5.008 Presynaptic interaction betweenrat brain dopaminergic and glutamatergic systems in the mechanism of action of the novel antiparicinsonian drug hemantane

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 97 KB

english, 2005

205

P.5.009 Reproductive toxicity of hemantane

N.M. Smolnikova, E.P. Nemova, A.X. Sorokina

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 86 KB

english, 2005

206

P.5.010 Stability of a novel antiparkinsoniandrug hemantane in aqueous solutions

L.N. Grushevskaya, E.A. Tsvetkova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 86 KB

english, 2005

207

P.5.011 Binding of regulatory neuropeptide [3H]-Semax (MEHFPGP), labeled in terminal Pro, to plasma membranes of the rat forebrain

T.V. V'unova, K.V. Shevchenko, V.P. Shevchenko, M.Yu. Bobrov, V.V. Bezuglov, N.F. Myasoedov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 108 KB

english, 2005

208

P.5.012 Coenzyme Q and α-tocopherol in rat brain during aging and after long-term coenzyme Q and α-tocopherol containing nutrient supplementation

E.I. Kalenikova, E.A. Gorodetskaya, A.N. Murashev, E.K. Ruuge, O.S. Medvedev

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 206 KB

english, 2005

209

P.5.013 Study of neurotropic effects ofSemax analogues depending on their structure

N.Yu. Glazova, N.G. Levitskaya, L.A. Andreeva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 100 KB

english, 2005

210

P.5.014 A novel method for memory dynamics evaluation can become the best test for early pre-diagnostics of Alzheimer's disease

N.S. Sapronov, I.I. Stepanov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 203 KB

english, 2005

211

P.5.015 The role of pineal gland peptides in regulationof free radical processes in aging

L.S. Kozina, V.Kh. Khavinson, A.V. Arutjunyan

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 200 KB

english, 2005

212

P.5.016 Stress-protective effect of mexidol on different levels of natural altitudes

U.M. Tilekeyeva, L.I. Sitina

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 97 KB

english, 2005

213

P.5.017 Antiamnesic action of zinc salts

A.Z. Zurdinov, G.M. Omorova, U.M. Tilekeeva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 188 KB

english, 2005

214

P.5.018 The role of M-cholinergic andGABA-ergic system in the development of the neuroleptics-induced extrapyramidal disturbances

S.G. Dagaev, O.A. Philko, N.E. Solovieva, L.G. Kubarskaya, A.V. Khrabrova, V.B. Dolgo-Saburov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 92 KB

english, 2005

215

P.5.019 Serum GFAP and DOPAC urinary excretion as markers of the efficacy of embryonic ventral mesencephalon transplantation into rats with hemiparkinsonism

V.P. Chekhonin, V.P. Baklaushev, O.I. Gurina, T.B. Dmitrieva, V.V. Belopasov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 195 KB

english, 2005

216

P.5.020 Targeted transport of PEGylatedimmunoliposomes to brain astrocytes

V.P. Chekhonin, Y.A. Zhirkov, O.I. Gurina, I.A. Rjabukhin, T.B. Dmitrieva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 105 KB

english, 2005

217

P.5.021 Influence of M- and N-cholinoblockers on principal manifestations of experimental parkinsonism induced by Nivalin and neurotoxine MPTP

N.A. Losev, N.S. Sapronov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 207 KB

english, 2005

218

P.5.022 Neuroprotective effect of Phytomix-40 in experimental parkinsonian syndrome

V.G. Kucheryanu, E.V. Bocharov, G.N. Kryzhanovsky, O.A. Bocharova, I.A. Ivanova-Smolenskaya, V.V. Poleschuk, V.S. Kudrin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 103 KB

english, 2005

219

P.5.023 Neurolipids: Fatty acid amides withserotonin and dopamine as antioxidants and neuroprotectors

M.Yu. Bobrov, N.M. Gretskaya, A.A. Lizhin, L.G. Khaspekov, V.V. Bezuglov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 208 KB

english, 2005

220

P.5.024 Transport of proserine through blood-brain barrier using poly(butylcyanoacrylate) nanoparticles coated with polysorbate-80 in rats

B.A. Abdel Wahab, V.E. Petrov, S.S. Trofimov, T.T. Voronina, R.N. Alyautdin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 213 KB

english, 2005

221

P.5.025 On the action of HSP70 preparation onthe central nervous system

L.I. Andreyeva, B.A. Margulis, I.V. Guzhova, P.D. Shabanov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 107 KB

english, 2005

222

P.5.026 Taurine rescues hippocampalsynaptic plasticity from ammonia-induced impairment

A.N. Chepkova, O.A. Sergeeva, H.L. Haas

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 211 KB

english, 2005

223

P.5.027 Ischemia-induced apoptosis and necrosis in the explant cultures of the rat organ of Corti

N. Andreeva, N. Amarjargal, H. Haupte, B. Mazurek, J. Grosse

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 201 KB

english, 2005

224

P.5.028 CB1 cannabinoid receptor-mediatedprotection against excitotoxic damage of hippocampal neurons in vitro: Histological and ultrastructural analysis

L. Khaspekov, M. Brenz Verca, L. Frumkina, D. Marsicano, H. Hermann, U. Heinzmann, L. Jennen, B. Lutz

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 97 KB

english, 2005

225

P.5.029 Putative protective role of glutamateantibodies in Alzheimer's disease

T.V. Davidova, V.G. Fomina, N.I. Voskresenskaya, L.A. Vetrile, N.A. Trekova, O.A. Doronina

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 105 KB

english, 2005

226

P.5.030 The nitric oxide system in the development of psychoemotional changes in rats under the conditions of hypokinesia

V.P. Hakobyan, K.B. Ashrafyan

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 205 KB

english, 2005

227

P.5.031 Changes of GABA content in different rat brain regions under the conditions of experimental hypokinesia

V.H. Karapetyan

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 101 KB

english, 2005

228

P.5.032 Calcium homeostasis and signal transduction alternations in rat brain cortex under the influence of hypokinesia and GABA

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 201 KB

english, 2005

229

P.5.033 GABA-receptor macromolecular complexes in rat brain under the conditions of passive readaptation after hypokinesia

L.S. Balyan, N.G. Avetisyan

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

230

P.5.034 Peculiarities of seizure responses in F18 generation of Long-Evans hooded rats following inbreeding

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 109 KB

english, 2005

231

P.5.035 Effects of thioperamide and raclopride on the striatal extracellular level of dopamine and histamine in Krushinsky-Molodkina and Wistar rats

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 210 KB

english, 2005

232

P.5.036 Role of lipid peroxidation and metabotropic glutamate receptors during experimental audiogenic seizures

L.A. Mahkova, O.G. Alekseeva, V.G. Bashkatova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

233

P.5.037 Clinical pharmaco-EEG characteristic ofthe novel nootropic drug noopept

I.A. Davidova, V.K. Bochkarev, G.G. Neznarnov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 209 KB

english, 2005

234

P.5.038 Clinical pharmacological study of thenovel peptide nootropic drug noopept

E.S. Teleshova, I.A. Davydova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 107 KB

english, 2005

235

P.5.039 Experimental and clinicalpharmacokinetics of noopept

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 202 KB

english, 2005

236

P.5.040 Individualizing dosage regimens of antiepileptic drugs: Multiple Model (MM) adaptive control

I.B. Bondareva, R.W. Jelliffe

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 202 KB

english, 2005

237

P.5.041 Clinical encephalographic analysis of the use of nooclerin with patients suffering from epilepsy

T.A. Rogacheva, T.C. Melnikova, V.N. Krasnov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 105 KB

english, 2005

238

P.5.042 Enhancement of the activity of antiepileptic drugs in combination with mexidol

Yu.V. Solomatin, T.A. Voronina, L.N. Nerobkova, G.N. Avakian, M.I. Stoiko, A.K. Aliev, O.L. Badalian

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 197 KB

english, 2005

239

P.5.043 Changes in lymphocytes functionalactivity as an indication of the epileptic preconvulsive status

I.A. Lioubimov, P.G. Nazarov, T.N. Savateeva, A.V. Savateev, V.I. Gouseva, M.I. Scharf

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 92 KB

english, 2005

240

P.5.044 Psychological features of patients withmigraine

A.D. Mochalov, A.V. Alexandrova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 195 KB

english, 2005

241

P.5.045 Succinate-containing drug attenuates cognitive disorders caused by traumatic brain injury in clinical setting

T.N. Savateeva, A.D. Tsivinsky, A.N. Petrov, A.V. Afanasiev, A.L. Kovalenko

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

242

P.5.046 Clinical and immunological study ofpatients with psychogenic asthenia: The way for optimization of therapy

I.N. Moroz, O.I. Gurina, O.L. Palko, D.L. Novikov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 98 KB

english, 2005

243

P.5.047 Effect of anxiety and depression on the efficiency of treatment of torticollis patients

E.V. Guzanova, V.N. Grigorieva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 98 KB

english, 2005

244

P.5.048 Botulinum toxin in focal dystoniapatients

E.A. Antipenko, L.M. Anisimova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 196 KB

english, 2005

245

P.5.049 The influence of memantine on cognitionin Alzheimer's disease, mixed dementia and dementia with Lewy bodies

N.N. Yachno, I.S. Preobrazhenskaya, E.A. Mkhitaryan

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 100 KB

english, 2005

246

P.5.050 The efficacy of treatment with tanakan (EGb 761) in relation to cognitive impairment in patients with cerebrovascular disease

V.V. Zakharov, N.N. Koberskaya, A. Charway, A.B. Lokshina

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 203 KB

english, 2005

247

P.5.051 The efficacy of nootropics and antihypoxants in correction of posttraumatic disorders of the brain

I.P. Zarubina, F.N. Nurmanbetova, P.D. Shabanov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

248

P.5.052 Early benefit of interferon β-1b inneuropsychiatric abnormalities in multiple sclerosis

C.A. Sirbu, D. Constantin, A. Tirca, N. Popa, A. Ocneanu, R. Munteanu, A. Chirtes, R. Nitulescu, F. Cristea

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 204 KB

english, 2005

249

P.5.053 Effects of N-cholinergic drugs on behavior in the explorative cross-maze in mice: Comparison with cognitive enhancers

R.M. Salimov, G.I. Kovalev

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 102 KB

english, 2005

250

P.5.054 Dopaminergic regulation of cognitive functions under acute stress conditions in rats

N.A. Bondarenko, O.N. Vorontsova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 105 KB

english, 2005

251

P.5.055 Effects of dipeptide nootropic noopept on immunity parameters in stressed CBA, C57BL/6 and F1(CBA×C57BL/6) mice

E.V. Shipaeva, L.P. Kovalenko

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 199 KB

english, 2005

252

P.5.056 Novel nootropic peptide Semax, anACTH4-10 analogue, enhances effects of d-amphetamine on the extracellular dopamine level in rat striatum and on locomotor activity of C57B/6 mice

K.O. Erernin, P. Saransaari, S. Oja, K.S. Rayevsky

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 96 KB

english, 2005

253

P.5.057 Regulation of neurotrophin level in the brain is a novel property of neuroprotective and nootropic melanocortin peptides

C.A. Karpenko, O.V. Dolotov, T.S. Seredenina, L.S. Inozemtseva, N.G. Levitskaya, J. Rozyczka, M. Figiel, A.A. Kamensky, I.A. Grivennikov, N.F. Myasoedov, J. Engele

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

254

P.5.058 Intramuscular injections of heparin improvethe learning process and change the mediator exchange in Wistar rat brain

M.V. Kondashevskaya, V.S. Kudrin, P.M. Klodt, L.A. Malikova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 208 KB

english, 2005

255

P.5.059 Behavioral consequences of combined manganese and piracetam administration

A.N. Petrov, M.K. Shevchuk, E.A. Kucher, A.V. Lychakov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 105 KB

english, 2005

256

P.5.060 Antiamnestic mechanisms of CK2 modulators in old rats

B.A. Reichardt, N.S. Sapronov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 206 KB

english, 2005

257

P.5.061 Nootropic activity and mechanism of action of the new 4-aminouracyl derivative

I.A. Myagkova, D.G. Kovalev, T.M. Lisenko

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

258

P.5.062 Design of nootropic dipeptides using the evolutional-genetic approach

A.A. Morozova, S.S. Trofimov, S.V. Nikitin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 207 KB

english, 2005

259

P.5.063 Effects of nooglutyl on learning and memory in rats with cholinergic deficit

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 105 KB

english, 2005

260

P.5.064 The effect of the novel selectiveanxiolytic afobazole in rats with experimentally produced hemorrhagic stroke

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 204 KB

english, 2005

261

P.5.065 Neuroprotective effect of nooglutylin rats with experimentally produced hemorrhagic and ischemic stroke

T.L. Garibova, T.A. Voronina, I.P. Galaeva, V.A. Krajneva, O.V. Povorova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 102 KB

english, 2005

262

P.5.066 Neuroprotective properties of the novelnootropic dipeptide noopept (GVS-111) on the model of severe brain ischemia

K.S. Us, S.A. Gavrilova, V.B. Koshelev

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 107 KB

english, 2005

263

P.5.067 Phenomenon of delayed neurodegenerationin rats in modelling brain ischemia

S.V. Lebedev, S.V. Petrov, D.V. Blinov, O.I. Gurina, V.P. Chekhonin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 201 KB

english, 2005

264

P.5.068 Objective characterization of behavioral disturbance within two months after middle cerebral artery occlusion

S.V. Petrov, S.V. Lebedev, V.P. Chekhonin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 97 KB

english, 2005

265

P.5.069 Objective test of motor asymmetryfollowing focal and global cerebral ischemia

S.V. Lebedev, S.V. Petrov, D.V. Blinov, P.E. Posobilo, V.P. Chekhonin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 97 KB

english, 2005

266

P.5.070 GABA-ergic mechanisms of cerebrovascular effects of novel neuroprotective drugs

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 108 KB

english, 2005

267

P.5.071 The peculiarities of the action of Vinpocetine, Nimodipine and Cinnarizine on sensitivity of cerebral vessels to carbon dioxide in rats under condition of hypokinesia

A.V. Baykov, A.S. Harutyunyan

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 205 KB

english, 2005

268

P.5.072 Memory restoring and neuroprotective effects of dipeptide noopept in a photochemical stroke model

G.A. Romanova, F.M. Shakova, T.A. Gudasheva, R.U. Ostrovskaya, T.A. Voronina

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 99 KB

english, 2005

269

P.5.073 Neuroprotective activity ofproproten in experimental model of cerebral hemorrhagic stroke

S.A. Sergeeva, J.L. Dugina, A.V. Martvushev-Poklad, D.I. Epstein

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 197 KB

english, 2005

270

P.5.074 New antiischemic drug composition

E.V. Lunshina, N.R. Mirzoyan

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 201 KB

english, 2005

271

P.5.075 Effect of esafosfina on cerebral microcirculation in intact and ischemized rat brain

V.V. Alexandrin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 103 KB

english, 2005

272

P.5.076 Analysis of cerebrovascular andneuroprotective effects of afobazole

I.V. Silkina, V.V. Alexandrin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 207 KB

english, 2005

273

P.5.077 Effect of docosahexaenoic dopamine oncerebral circulation in rats after global reversible brain ischemia

N.A. Khailov, V.V. Bezuglov, N.M. Gretskaia

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 105 KB

english, 2005

274

P.5.078 Acute focal cerebral ischemia andcoenzyme Q

O.V. Povarova, E.I. Kalenikova, O.S. Medvedev

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 207 KB

english, 2005

275

P.5.079 Insulin-like growth factor immunoreactivityin rat cerebellum after acute and repeated unilateral brain injury

G. Grbic, Lj. Martac, M. Culic, V. Todorovic, O. Mitrovic, S. Spasic

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

276

P.5.080 Afobazole protects neurons against oxidative stress and glutamate toxicity in vitro

T.A. Zenina, I.V. Gawrish, D.S. Melkumyan, T.S. Seredenina

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 102 KB

english, 2005

277

P.5.081 Nitric oxide and oxidative stress in the mechanisms of dopaminergic neurotoxicity: Possible neuroprotective approaches

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 205 KB

english, 2005

278

P.5.082 Gender differences in the effect ofnootropic medicine, noopept, in the model of early postnatal hypoxia

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 105 KB

english, 2005

279

P.5.083 Multicomponent action of psychotropicdrugs on activated neutrophilic leukocytes

L.P. Kovalenko, E.V. Shipaeva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 208 KB

english, 2005

280

P.5.084 Pharmacokinetics and biotransformation of mexidol in C57BL/6 and BALB/C inbred mice

O.Yu. Kravtsova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

281

P.5.085 Comparative study of antimigraineactivity of tropoxin and other antimigraine medicaments

T.S. Ganshina, S.G. Bezhanyan, I.M. Kostochka

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 213 KB

english, 2005

282

P.5.086 Correction of motor disturbances inrats with perinatal hypoxic-ischaemic affection of the CNS by transplantation of embryonal nervous cell preparation into the hippocamp CAI zone

V.P. Chekhonin, S.V. Lebedev, D.V. Blinov, E.A. Savchenko, I.P. Lazarenko, A.I. Volkov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 209 KB

english, 2005

283

P.5.087 The content of monoamines and theirmetabolites in the brain structures of mdx mice with progressive muscular dystrophy

A.A. Pokrovsky, V.S. Kudrin, P.M. Klodt, V.F. Sitniko, A.B. Kuznetsov, A.I. Matyushin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 101 KB

english, 2005

284

P.5.088 Toxicity of excitatory amino acids in organotypic retinal cultures of postnatal and adult rats

I. Victorov, O. Aleksandrova, N. Alekseeva, A. Lyjin, S. Rzeczinski, U. Dirnagl

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 197 KB

english, 2005

285

P.5.089 Autoimmune responses to proteins HLDF and S100b as pathogenic factors and molecular markers of cerebrovascular diseases

E.I. Elistratova, N.E. Yakovleva, V.V. Sherstnev, I.S. Denischuk, V.V. Yurasov, I.A. Kostanyan, E.A. Shirokov, V.I. Skvortzova, M.A. Gruden

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 98 KB

english, 2005

286

P.5.090 Cytokine mechanisms of glutamate modulationof demyelinating process under experimental allergic encephalomyelitis

I.N. Abdurasulova, Y.L. Zhitnukhin, V.E. Gmiro, V.M. Khmenko

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

287

P.5.091 Experimental estimation of effects oferythropoietin on consequences of spinal injury

M.M. Odinak, N.V. Tsygan

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 206 KB

english, 2005

288

P.5.092 Impacts of prenatal stress and dexamethasone administration on the structure of neocortex and hippocampus

V.A. Otellin, L.I. Khozhay, D.E. Korzhevskii, E.G. Gilerovich, I.P. Grigorev

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

289

P.5.093 Study of the behavior of white rats with destroyed olfactory epithelium

T.I. Kydyakova, N.Yu. Sarycheva, A.A. Kamensky

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 98 KB

english, 2005

290

P.5.094 Drug-based design of biologicallyactive dipeptides

T. Gudasheva, R. Ostrovskaya

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 98 KB

english, 2005

291

P.5.095 Influence of cholinergic and GABA-ergicdrugs on the recovery cycles of septo-hippocampal and somatosensorial primary evoked responses

G.M. Molodavkin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

292

P.5.096 The influence of calcium channel blockade on rat picrotoxin-induced hyperkinesis

A.F. Yakimovski, V.M. Varszavskaja

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

293

P.5.097 Effect of lamictal on EEG paroxysmal activity of the female rat brain in different stages of the oestrous cycle

F.K. Rider, T.A. Voronina, G.N. Avakian, S.G. Burd, L.N. Nerobkova, Yu.V. Solomatin, T.S. Kalinina, A.V. Volkova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

294

P.5.098 The combined blockade of GluR1 AMPA receptors and α3β4 N-cholinoreceptors inhibits generation of limbic seizures caused by kainate and nicotine

V.E. Gmiro, S.E. Serdyuk

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 200 KB

english, 2005

295

P.5.099 Influence of the polyamine sitemodulators on NMDA-induced convulsions in mice

O.M. Efremov, S.E. Serdyuk, V.E. Gmiro

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 98 KB

english, 2005

296

P.5.100 Peptidergic strategy of pharmacologicalcorrection of asthenic disorders

I.B. Ushakov, V.L. Barabash, R.A. Bondarenko

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 111 KB

english, 2005

297

P.5.101 Electrophysiological patterns of brain activation in persons at familial risk for Alzheimer's disease

N.V. Ponomareva, N.D. Selesneva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 208 KB

english, 2005

298

P.5.102 Change of cerebral acid-base balance with chronic brain ischemic disease in response to vinpotropil therapy

V.F. Fokin, E.I. Ivashtenko

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 99 KB

english, 2005

299

P.5.103 Neuroprotective effect of a syntheticpeptide mimetic of neural cell adhesion molecule, P2, in an in vitro model of ischemic damage

K.Y. Voronin, I.V. Lushnikova, G.G. Skibo, V.A. Berezin, E. Bock

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 197 KB

english, 2005

300

P.5.104 The study of protective properties ofL-phenylalanine on the model of stroke (hippocampal slice culture exposed to oxygen-glucose deprivation)

P.Y. Malyarevskyy, I.V. Lushnikova, A.E. Martynyuk, G.G. Skibo

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 100 KB

english, 2005

301

P.5.105 Action of β-amyloid peptide and TNF-αon sphingomyelin cycle signaling system and lipid peroxide oxidation in rat brain sections

A.E. Bugrova, L.B. Dudnik, A.V. Alessenko

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 204 KB

english, 2005

302

P.5.106 Psychotropic action of taftsin derivateSelank

M.M. Kozlovskaya, I.I. Kozlovsky, M.V. Levina, I.V. Ribina, M.A. Yarkova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

303

P.5.107 Ischemized brain protection by modulatorsof GABA-ergic neurotransmission

M.G. Balasanyan, H.V. Topchyan, A.S. Kanayan

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 204 KB

english, 2005

304

P.5.108 Efficacy and safety of rivastigmine in patients with mixed dementia

A. Baloescu, G. Grigorescu

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 99 KB

english, 2005

305

P.5.109 Psychiatric disorders in adolescents with juvenile myoclonic epilepsy

N.J. Jovic, V.A. Milovanovic

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 206 KB

english, 2005

306

P.5.110 Can ampakines reverse cognitivedeficits in healthy adults?

A. Mishory, E. Grenesko, B. Anderson, Z. Nahase, M. Horner, S. Johnson, G. Rogers, M.S. George

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 111 KB

english, 2005

307

P.6.001 Glucocorticoids can play a dual role in the activation of the reinforcing system of the brain: Directly activate the system and modulate the dopaminergic mechanisms of reward

P.D. Shabanov, A.A. Lebedev, V.V. Russanovsky, V.P. Pavlenko, V.F. Streltsov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

308

P.6.002 Mechanism of CCK-4 analogue activity in morphine-dependent rats

T.V. Proskuryakova, O.B. Petrichenko, V.A. Shokhonova, I.P. Anokhina

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 214 KB

english, 2005

309

P.6.003 Effects of galavit on the nitrergic system in rat brain regions during morphine withdrawal

D.I. Peregud, M.V. Onufriev, L.F. Panchenko, N.V. Gulyaeva, V.M. Polosin, V.K. Zhilov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 111 KB

english, 2005

310

P.6.004 Blood lymphocyte adenylate cyclase complex in rats with different susceptibility to opiate dependence

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 102 KB

english, 2005

311

P.6.005 Experimental study of the effect ofcorticosteroid derivatives on craving for alcohol and morphine

A.V. Stanishevskaya, N.L. Vekshina, I.V. Vesela

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 206 KB

english, 2005

312

P.6.006 Ethanol and beta-endorphin.Microelectrophoretic study on frontal cortical neurons of the brain

S.N. Kozhechkin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 107 KB

english, 2005

313

P.6.007 Experimental pharmacological evaluation of Sydnocarb effects: Comparisons with methamphetamine

N.M. Savchenko, J.M. Witkin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 206 KB

english, 2005

314

P.6.008 The biological activity of a novel fragmentof the natural precursor of dermorphin-Arg-dermorphin and its analogues

L.S. Guzevatikh, T.G. Emel'yanova, L.A. Andreeva, T.A. Voronina, N.F. Myasoedov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 206 KB

english, 2005

315

P.6.009 Behavioural effects of cholecystokinin-4 dipeptide retro-analog in naive and morphine-dependent rats

M.A. Konstantinopolsky, A.I. Maisky, T.A. Gudasheva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

316

P.6.010 Antioxidants in protecting erythrocyte proteins against damage under influence of acetaldehyde

V.D. Prokopieva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 207 KB

english, 2005

317

P.6.011 New highly active thebaine analgesics

T.G. Tolstikova, E.E. Shultz, M.P. Dolgikh, I.V. Sorokina, G.A. Tolstikov, N.N. Vorozhtsov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 204 KB

english, 2005

318

P.6.012 Chronic ethanol administration and hippocampal neurogenesis

K. Jaako-Movits, T. Zharkovsky, A. Kaasik, A. Zharkovsky

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 101 KB

english, 2005

319

P.6.013 2-Amino-adamantane derivativeLadasten enhances ex vivo dopamine synthesis and release in rat striata

G.B. Lapa, G.I. Kovalev

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 202 KB

english, 2005

320

P.6.014 On combination relapse preventiontreatment in alcoholic dependency

V. Chirko, T.N. Dudko

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

321

P.6.015 Metabolic and reinforcing effects of ADH1B-1/1 genotype, and possibilities of siccine acid dietary supplements

P.P. Ogutsov, I.V. Garmash, N.S. Ovchinnikova, Y.D. Pomyotov, V.P. Nuzhnyi

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 203 KB

english, 2005

322

P.6.016 In vivo repeated alcohol craving assessment using electronical diary during alcohol withdrawal

M. Lukasiewicz, A. Benyamina, M. Reynaud, B. Falissard

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 101 KB

english, 2005

323

P.6.017 The study of mirtazapine efficacy in the treatment of alcohol dependence

T.V. Agibalova, M.V. Zakharovov, A.S. Lobacheva, P.V. Lomakin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 204 KB

english, 2005

324

P.6.018 The use of balanced aminoacid“Aminosol KE” for treatment of post-withdrawal disorders in chronic alcoholism patients

S.Y. Utkin, N.V. Strelets

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 105 KB

english, 2005

325

P.6.019 Normothymics in treatment of alcohol craving: Results of a comparative study

M.A. Vinnikova, N.N. Ivanets, T.V. Agibalova, I.V. Zhirov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 203 KB

english, 2005

326

P.6.020 Use of the neurometabolic drug “Semax” for complex treatment of alcohol delirium

N.V. Strelets, S.Y. Utkin

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 102 KB

english, 2005

327

P.6.021 Cerebrolysin in the treatment of cerebralatrophic changes in alcoholic patients

M.Ye. Tuchkova, S.L. Kravchenko, V.B. Altshuler

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 105 KB

english, 2005

328

P.6.022 Reception of dopamine and morphine by the peripheral blood lymphocytes of alcoholic patients with different response to pyrotherapy

N.B. Gamaleya, N.E. Makarova, V.V. Nikolaeva, O.A. Shostak

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 209 KB

english, 2005

329

P.6.023 Action of chronic caffeine consumption on individual sensitivity to morphine, ethanol and nicotine

I.V. Rusakova, S.K. Sudakov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 106 KB

english, 2005

330

P.6.024 Citalopram in the treatment of alcohol dependence

T.P. Nebarakova, T.B. Basmanova, A.S. Lobacheva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 209 KB

english, 2005

331

P.6.025 Comparative efficiency of quetiapine fumarate in treatment of patients with alcohol dependence

A.G. Gofman, E.N. Krilov, Y.E. Varfolomeeva, P.A. Ponizovskiy

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 105 KB

english, 2005

332

P.6.026 Risperidone in the treatment of alcoholdependence

D.V. Borisov, T.P. Nebarakova, T.B. Basmanova, M.A. Roslova, V.V. Klinkov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 207 KB

english, 2005

333

P.6.027 Association study of tyrosine hydroxylaseand dopamine receptor type 2 gene polymorphisms and heroin addiction with a family history of alcoholism

A.O. Kibitov, E.Yu. Voskoboyeva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

334

P.6.028 Opiate receptors blockers in the treatment of alcohol dependence

I.V. Zhirov, M.A. Vinnikova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 211 KB

english, 2005

335

P.6.029 The clinical characteristics of long-termbenzodiazepine users with neurotic spectrum disorders

D.V Yastrebov, O.A. Cheberda

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 216 KB

english, 2005

336

P.6.30 Antirelapsing risperidone monotherapy of drug addiction

I.A. Nosatovsky, E.N. Krilov, V.V. Khanikov, A.G. Gofman

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 108 KB

english, 2005

337

P.6.031 The danger of cocaethylene use in thefield of drug addiction

E. Peppas, J. Liappas, P. Theothoropoulos, L. Chaziroglou, K. Soldatos

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 211 KB

english, 2005

338

P.6.032 Pica, anxiety and addiction: Mechanismsand therapy

T. Nevidimova, V. Semke, N. Bokhan

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 105 KB

english, 2005

339

P.6.033 Combined Prodetoxon (naltrexone-long)and Vitagam-Rulin treatment of opiate addicted patients

L.D. Mikhaleva, A.V. Yukhimenko, G.Yu. Soulimov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 202 KB

english, 2005

340

P.6.034 Naltrexone and craving: Does it work with eating disorders?

M. Campana, M. Riglietta

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 98 KB

english, 2005

341

P.6.035 Clinical and experimental study of the effect of antaxone on dopamine neurotransmission in opiate dependence

A.G. Veretinskaya, N.L. Vekshina

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 204 KB

english, 2005

342

P.6.036 A double-blind, placebo controlled trial of naltrexone and fluoxetine for heroin addiction treatment

E. Krupitsky, E. Zvartau, D. Masalov, M. Tsoi, V. Egorova, A. Burakov, T. Didenko, T. Romanova, E. Verbitskava, A. Bespalov, N. Neznanov, A. Grinenko, G. Woody

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 109 KB

english, 2005

343

P.6.037 Craving in heroine addicts maintainedon naltrexone

V. Egorova, E. Krupitsky, E. Zvartau, D. Masalov, M. Tsoi, A. Burakov, T. Didenko, T. Romanova, A. Bespalov, E. Verbitskaya, E. Ivanova, N. Nemanov, A. Grinenko, G. Woody

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 109 KB

english, 2005

344

P.6.038 Statistical analysis of double blind placebo controlled clinical trial of heroin addiction treatment by naltrexone and fluoxetine combination

E.V. Verbitskaya, E.M. Krupitsky, E.E. Zvartau

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 217 KB

english, 2005

345

P.6.039 Efficacy of zuclopentixol treatmentof withdrawal syndrome in opiate dependent patients

A.V. Khotovitski, V.V. Klinkov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 111 KB

english, 2005

346

P.6.040 Treatment of craving for drugs withrisperidone in patients with heroin addiction

S.O. Mokhnatchev, M.V Zakharov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 101 KB

english, 2005

347

P.6.041 Dopamine D2 receptor gene and drug abuse: Prevalence of combined A1/A2 Taql A and C/C Ncol genotypes in alcohol- and heroin-dependent patients

I.Yu. Shamakina, A.I. Kibitov, E.Yu. Voskoboeva, A.G. Veretinskaya, I.P. Anokhina

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 101 KB

english, 2005

348

P.6.042 Aprotinin as a new drug for treatment of opiate withdrawal syndrome

S.K. Sudakov, I.V. Rusakova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 100 KB

english, 2005

349

P.6.043 Pirlindol in the treatment of heroin addicted patients

A.V. Rusinov, S.L. Kravchenko, V.B. Altshuler

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 100 KB

english, 2005

350

P.6.044 The treatment of algesic disorders inopiate-addicted patients by the use of endogenous peptides

V.B. Altshuler, T.Ye. Galactionova, S.L. Kravchenko

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 110 KB

english, 2005

351

P.6.045 Pyrogenal in the treatment of sleepdisorders in heroin-addicted patients

N.Ye. Makarova, V.B. Altshuler

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 212 KB

english, 2005

352

P.6.046 On the use of intravenous drop-by-drop infusion of neuroleptics with the purpose to retain heroin-addicted patients in treatment programme

S.V. Kotov, M.V. Demina

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 104 KB

english, 2005

353

P.6.047 Non-steroidal anti-inflammatory drugsin the treatment of opiate withdrawal syndrome

O.I. Rusinova, D.V. Borisov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 205 KB

english, 2005

354

P.6.048 Experience in the use of a neuroleptic with prolonged action for the treatment of heroin addicted patients

M.V. Demina, S.V. Kotov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 103 KB

english, 2005

355

P.6.049 Influence of sucrose and saccharin onprimary-reinforcing effect of ethanol in DBA/2 mice

M.V. Tsoy, N.A. Patkina, E.E. Zvartau

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 202 KB

english, 2005

356

P.6.050 Neuronal mechanisms of resistance to stress and drug addiction: Role of CRF and ACTH14–10

E.V. Borisova, A.F. Mescheryakov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 102 KB

english, 2005

357

P.6.051 Evaluation of the influence of organospecific remedies from the peritoneal liquid on ethanol intoxication in laboratory mice

N.M. Pozdeyev, N.V. Ryabov, A.N. Napalkov, A.B. Kozachuk

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 202 KB

english, 2005

358

P.6.052 Study of the sobering effect of remedy Ru21-green

V.P. Nuzhnyi, Y.D. Pomyotov, A.N. Martyushov, A.V. Kovalyova, I.R. Andreeva, A.P. Efremov, V.V. Rozhanets

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 102 KB

english, 2005

359

P.6.053 The influence of aqueous extracts of Inula sp. on the pharmacodynamic action and pharmacokinetic parameters of ethanol in experimental animals

I.G. Zabirova, V.P. Nuzhnyi, A.P. Efremov, V.P. Listvina, L.A. Surcova, L.V. Samoilic, J.A. Lvova, V.V. Rozhanets

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 202 KB

english, 2005

360

P.6.054 The influence of processed extract ofbroccoli (Brassica oleracea var. italica) seeds on the pharmacodynamics and pharmacokinetic parameters of ethanol in rats

V.V. Rozhanets, I.G. Zabirova, V.P. Listvina, L.A. Surcova, L.V. Samoilik, J.A. Lvova, V.P. Nuzhnyi

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 101 KB

english, 2005

361

P.6.055 Reinforcing properties of neuropeptidesadministered into the extended amygdala of chronically alcoholized rats

A.A. Lebedev, E.E. Voevodin, L.I. Andreeva, V.V. Russanovsky, V.P. Pavlenko, V.F. Streltsov, P.D. Shabanov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 101 KB

english, 2005

362

P.6.056 Substance P affects alcohol intake bydopamine-dependent mechanism and displays altered reinforcing properties in ethanol-treated rats

S.V. Nikolaev, E.R. Bychkov, A.A. Lebedev, P.D. Shabanov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 207 KB

english, 2005

363

P.6.057 The effect of HLDF-6 peptide on formationof morphine tolerance and abusing symptoms: Enkephalinase mechanisms

L.F. Panchenko, S.V. Litvinova, A.L. Kaluzhnyi, V.V. Aristova, V.V. Shulgovski, N.N. Terebilina, I.A. Kostanyan

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 108 KB

english, 2005

364

P.6.058 Inducible nitric oxide synthase in the locus coeruleus of human opiate addicts

I.V. Dyuizen, R.A. Kurbatskii, G.G. Dirlam, V.B. Kozhemyako, M.S. Zavgorodnyaya

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 214 KB

english, 2005

365

P.6.059 Search for opiate antagonistsin a series of derivatives of 3,7-diazobicyclo[3.3.1 ]nonane

K.D. Praliyev, T.K. Iskakova, M.S. Lukyanova, V.K. Yu, A.A. Koltunova, Zh.M. Zhaksybaeva, G.A. Akhmetova, R.A. Ivanova, L.M. Moiseeva

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 205 KB

english, 2005

366

P.6.06C Alcohol modulates the properties of benzodiazepine receptors and neuroendocrine functions

T.V. Shushpanova

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 98 KB

english, 2005

367

P.6.061 Influence of alcohol onpharmacokinetics of novel highly efficient anticonvulsant

T.V. Shushpanova, T.P. Novozheeva, O.V. Shushpanova, A.S. Saratikov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 98 KB

english, 2005

368

P.6.062 Influence of maternal alcoholism onultrastructural alterations of cells of human embryonic brain

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 100 KB

english, 2005

369

P.6.063 Clinical and biological effectiveness of anar therapy in opiate addicts

N.A. Bokhan, S.A. Ivanova, T.P. Vetlugina, S.A. Sergeeva, O.I. Epstein

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 100 KB

english, 2005

370

P.6.064 Influence of alcohol dependence on oxidative metabolism of xenobiotics in humans

V.Ya. Semke, T.P Novozheeva, T.V. Shushpanova, L.A. Gorbatchevich, V.F. Lebedeva, I.E. Kupriyanova, M.M. Aksjenov

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 76 KB

english, 2005

371

P.6.065 Behavioral differences between alcohol-dependent mice forcibly treated or not treated with water

R.A. Akhundov, F.I. Jafarov, A.S. Khudaverdijev

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 76 KB

english, 2005

372

Author index

Journal:

European Neuropsychopharmacology

Year:

2005

File:

PDF, 588 KB

2005

373

Keyword index

Journal:

European Neuropsychopharmacology

Year:

2005

Language:

english

File:

PDF, 330 KB

english, 2005